Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DOCS
DOCS logo

DOCS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Doximity Inc (DOCS) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast DOCS stock price to rise
18 Analyst Rating
Wall Street analysts forecast DOCS stock price to rise
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 21.070
sliders
Low
25
Averages
42.75
High
63
Current: 21.070
sliders
Low
25
Averages
42.75
High
63
Barclays
Overweight
to
Equal Weight
downgrade
$20
AI Analysis
2026-05-14
Reason
Barclays
Price Target
$20
AI Analysis
2026-05-14
downgrade
Overweight
to
Equal Weight
Reason
Barclays downgraded Doximity to Equal Weight from Overweight with a $20 price target.
Barclays
Overweight -> Equal Weight
downgrade
$38 -> $20
2026-05-14
Reason
Barclays
Price Target
$38 -> $20
2026-05-14
downgrade
Overweight -> Equal Weight
Reason
Barclays downgraded Doximity to Equal Weight from Overweight with a price target of $20, down from $38. Growth in the digital advertising space is slowing while competition is ramping, the analyst tells investors in a research note. As such, Barclays expects industry growth to remain \"lackluster,\" keeping shares of Doximity and Phreesia range-bound. Digital marketing industry players have been reporting slower growth in the past couple of quarters, the firm says. It sees no sign of this easing.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DOCS
Unlock Now

People Also Watch